STOCK TITAN

Ionis to present at upcoming investor conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS) announced participation in key investor conferences featuring fireside chats this September 2022. These events include the Wells Fargo Healthcare Conference on September 7, Citi's BioPharma Conference on September 8, and the Morgan Stanley Global Healthcare Conference on September 12. Live webcasts will be available on the Ionis website, with replays accessible within 48 hours post-event.

Ionis leads in RNA-targeted therapies, with three marketed medicines and a strong pipeline in cardiovascular and neurological sectors.

Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., Aug. 30, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

  • 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022
  • Citi's 17th Annual BioPharma Conference on Thursday, September 8, 2022
  • Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022

A live webcast and additional information about each fireside chat can be accessed on the Investors & Media section of the Ionis website at www.ionispharma.com. Replays will be available on the Ionis website within 48 hours of each event.

About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.

To learn more about Ionis, visit www.ionispharma.com and follow us on Twitter @ionispharma

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301614126.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

What investor conferences will Ionis Pharmaceuticals participate in September 2022?

Ionis Pharmaceuticals will participate in the Wells Fargo Healthcare Conference on September 7, Citi's BioPharma Conference on September 8, and the Morgan Stanley Global Healthcare Conference on September 12, 2022.

Where can I watch the Ionis Pharmaceuticals investor conference webcasts?

The webcasts for the Ionis Pharmaceuticals investor conferences can be accessed on the Investors & Media section of their website at www.ionispharma.com.

What is the ticker symbol for Ionis Pharmaceuticals?

The ticker symbol for Ionis Pharmaceuticals is IONS, traded on Nasdaq.

How can I access replays of the Ionis Pharmaceuticals conference presentations?

Replays of the Ionis Pharmaceuticals conference presentations will be available on their website within 48 hours after each event.

What is Ionis Pharmaceuticals known for?

Ionis Pharmaceuticals is known for its leadership in RNA-targeted therapies and its pioneering antisense technology, with a focus on cardiovascular and neurological treatments.

Ionis Pharmaceuticals, Inc.

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Stock Data

5.19B
145.97M
0.78%
99.5%
6.26%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CARLSBAD